Duncker Streett & Co’s Avanos Medical AVNS Stock Holding History

Duncker Streett & Co’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-93	Closed	-$3K	–	502
2020 Q2	$3K	Hold	93	–	–	﹤0.01%	484
2020 Q1	$3K	Hold	93	–	–	﹤0.01%	492
2019 Q4	$3K	Buy	+93	New	+$3.37K	﹤0.01%	522
2019 Q3	–	Sell	-93	Closed	-$4K	–	273
2019 Q2	$4K	Hold	93	–	–	﹤0.01%	517
2019 Q1	$4K	Hold	93	–	–	﹤0.01%	528
2018 Q4	$4K	Hold	93	–	–	﹤0.01%	527
2018 Q3	$6K	Hold	93	–	–	﹤0.01%	533
2018 Q2	$5K	Hold	93	–	–	﹤0.01%	544
2018 Q1	$4K	Hold	93	–	–	﹤0.01%	554
2017 Q4	$4K	Hold	93	–	–	﹤0.01%	552
2017 Q3	$4K	Hold	93	–	–	﹤0.01%	565
2017 Q2	$4K	Hold	93	–	–	﹤0.01%	574
2017 Q1	$4K	Hold	93	–	–	﹤0.01%	587
2016 Q4	$3K	Sell	93 -16	-15%	-$572	﹤0.01%	581
2016 Q3	$4K	Sell	109 -1	-0.9%	-$35	﹤0.01%	567
2016 Q2	$4K	Hold	110	–	–	﹤0.01%	556
2016 Q1	$3K	Sell	110 -20	-15%	-$533	﹤0.01%	569
2015 Q4	$4K	Hold	130	–	–	﹤0.01%	571
2015 Q3	$4K	Hold	130	–	–	﹤0.01%	577
2015 Q2	$5K	Hold	130	–	–	﹤0.01%	568
2015 Q1	$6K	Hold	130	–	–	﹤0.01%	555
2014 Q4	$6K	Buy	+130	New	+$5.11K	﹤0.01%	551

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Duncker Streett & Co's AVNS Position: Q3 2020 in Review

Duncker Streett & Co sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 93 shares — an estimated $3K sold.

Duncker Streett & Co first reported a position in AVNS in Q4 2014 and held it in 22 quarters. The position peaked at $6K in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

Duncker Streett & Co reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
Duncker Streett & Co sold 93 Avanos Medical shares in Q3 2020, an estimated $3K.
Duncker Streett & Co first reported a position in Avanos Medical in Q4 2014 and held it in 22 quarters.
Duncker Streett & Co's Avanos Medical position peaked at $6K in Q3 2018.
272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Duncker Streett & Co's 13F filing for Q3 2020, filed 28 Oct 2020.